Relyvrio

Generic name: Sodium Phenylbutyrate And Taurursodiol
Dosage form: powder for oral suspension
Drug class: Miscellaneous central nervous system agents

Usage of Relyvrio

Relyvrio is a prescription medicine used to treat adults with amyotrophic lateral sclerosis (ALS), commonly referred to as Lou Gehrig’s disease.

ALS is a neurodegenerative disease caused by motor neuron death in the brain and spinal cord.

The two ingredients contained in Relyvrio work together to reduce motor neuron cell death and inflammation, and slow down disease progression.

Relyvrio side effects

Relyvrio may cause serious side effects, including:

Changes in bile acid levels. Relyvrio may increase bile acid levels and cause worsening diarrhea if you already have problems with your liver, bile ducts, or pancreas. Your healthcare provider should monitor you for these side effects. Some disorders of the pancreas, bile ducts, or intestines may also make it harder to absorb Relyvrio.

Salt (sodium) retention. Relyvrio contains a high amount of salt. For people who are sensitive to salt intake, such as people with heart failure, high blood pressure, or kidney problems, limit the amount of salt you eat and drink.

Talk to your healthcare provider about the total amount of daily salt that is right for you. Your healthcare provider will monitor you for signs and symptoms of salt retention during your treatment.

The most common side effects include:

diarrhea

abdominal pain

nausea

upper respiratory tract infection.

Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all the possible side effects. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Relyvrio

Before you start treatment, tell your healthcare provider about all of your medical conditions, including if you:

have pancreas, liver, or intestinal problems.

have heart failure, including congestive heart failure.

have high blood pressure.

have kidney problems.

are pregnant or plan to become pregnant. It is not known if Relyvrio will harm your unborn baby.

are breastfeeding or plan to breastfeed. It is not known if Relyvrio passes into your breast milk. You and your healthcare provider should decide the best way to feed your baby.

Relate drugs

How to use Relyvrio

Usual Adult Dose for Amyotrophic Lateral Sclerosis

- The recommended dosage is 1 packet (3 g sodium phenylbutyrate and 1 g taurursodiol) daily for the first 3 weeks, and then 1 packet twice daily thereafter.

- Comment: can be administered orally or via feeding tube.

- Use: treatment of amyotrophic lateral sclerosis (ALS) in adults.

What other drugs will affect Relyvrio

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements, and any taurursodiol products, such as tauroursodeoxycholic acid (TUDCA).

Relyvrio may affect the way other medicines work, and other medicines may affect how Relyvrio works.

Especially tell your doctor if you take:

cholestyramine, colestipol, or colesevelam;

cyclosporine;

aluminum-based antacids;

probenecid;

vorinostat, romidepsin, panobinostat, or Belinostat.

There are many other drugs that may interact with Relyvrio. Check with your healthcare provider before you start treatment.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.